Levonorgestrel
(Redirected from Athentia Next)
Levonorgestrel is a synthetically derived progestin used primarily in emergency contraception and standard oral contraceptives. It acts as an agonist of the progesterone receptor, providing effective contraception by preventing ovulation.
Pharmacological Profile[edit | edit source]
Levonorgestrel operates as an emergency contraceptive by hindering the luteinizing hormone (LH) surge that precedes ovulation. Its efficiency is observed predominantly when administered before this LH surge, and it demonstrates minimal effects on fertilization or implantation.
Clinical Efficacy[edit | edit source]
Clinical studies have evidenced the efficacy of levonorgestrel in significantly lowering the rate of unwanted pregnancies when used within 48 hours of unprotected intercourse or suspected contraceptive failure. The overall failure rates range from 0.6% to 3.1%, compared to expected rates of 5% to 6%.
Approval and Usage[edit | edit source]
The United States Food and Drug Administration (FDA) approved levonorgestrel for emergency contraception use in 1982. Available generically and over-the-counter, it is administered in tablet form in doses of 0.75 and 1.5 mg. The recommended regimen for emergency contraception is a total dose of 1.5 mg, taken within 72 hours of unprotected intercourse or suspected contraceptive failure.
Levonorgestrel also serves as a constituent of standard oral contraceptives, where it is used alone or in combination with estrogens.
Safety Profile[edit | edit source]
The use of levonorgestrel has not been associated with liver enzyme elevations or clinically apparent liver injury with jaundice.
Adverse Effects[edit | edit source]
Potential side effects of levonorgestrel use, generally mild-to-moderate in severity, can include headache, nausea, abdominal pain, dysmenorrhea, breast tenderness, fatigue, and dizziness.
Obstetrical and Gynecological Agents[edit source]
- Pregnancy termination agents
- Progesterone and the Progestins
Levonorgestrel Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD